|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.01(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,000 |
384,322 |
579,546 |
794,601 |
Total Sell Value |
$42,551 |
$21,525,712 |
$32,066,990 |
$40,646,784 |
Total People Sold |
1 |
4 |
8 |
10 |
Total Sell Transactions |
2 |
10 |
25 |
62 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shandell Jason B. |
President and General Counsel |
|
2019-03-26 |
4 |
D |
$20.54 |
$135,626 |
D/D |
(6,603) |
169,425 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-03-26 |
4 |
D |
$20.54 |
$52,439 |
D/D |
(2,553) |
86,339 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-03-17 |
4 |
D |
$20.23 |
$105,762 |
D/D |
(5,228) |
88,892 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-03-17 |
4 |
D |
$20.23 |
$26,441 |
D/D |
(1,307) |
42,158 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2019-03-17 |
4 |
D |
$20.23 |
$30,547 |
D/D |
(1,510) |
57,921 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$654,926 |
D/D |
(32,374) |
2,147,316 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2019-03-17 |
4 |
D |
$20.23 |
$199,791 |
D/D |
(9,876) |
176,028 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-03-16 |
4 |
D |
$20.23 |
$89,761 |
D/D |
(4,437) |
94,120 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-03-16 |
4 |
D |
$20.23 |
$24,944 |
D/D |
(1,233) |
43,465 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2019-03-16 |
4 |
D |
$20.23 |
$31,417 |
D/D |
(1,553) |
59,431 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$239,361 |
I/I |
(11,832) |
1,412,963 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$555,839 |
D/D |
(27,476) |
2,179,690 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2019-03-16 |
4 |
D |
$20.23 |
$169,548 |
D/D |
(8,381) |
185,904 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-03-15 |
4 |
D |
$20.23 |
$59,557 |
D/D |
(2,944) |
98,557 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,951 |
101,501 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-03-15 |
4 |
D |
$20.23 |
$21,666 |
D/D |
(1,071) |
44,698 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,886 |
45,769 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2019-03-15 |
4 |
D |
$20.23 |
$23,851 |
D/D |
(1,179) |
60,984 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,133 |
62,163 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
D |
$20.23 |
$4,211,279 |
I/I |
(208,170) |
1,424,795 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,522 |
1,432,112 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$3,559,834 |
I/I |
224,737 |
1,591,443 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
D |
$20.23 |
$9,676,049 |
D/D |
(478,302) |
2,207,166 |
|
- |
|
Luo Mary Z. |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
98,368 |
2,224,371 |
|
- |
|
956 Records found
|
|
Page 19 of 39 |
|
|